Search — EtoBox

7 works shown

Showing the first matches. Checking the full catalogue…

Books

Full Elucidation of the Transmembrane Anion Transport Mechanism of Squaramides Using in Silico Investigations

Igor Marques & Pedro M. R. Costa & Margarida Q. Miranda & Nathalie Busschaert & Ethan N. W. Howe & Harriet J. Clarke & Cally J. E. Haynes & Isabelle L. Kirby & Ananda M. Rodilla & Ricardo P & #xe9, rez-Tom & #xe1 & 2 more

PDF5.4 MB

A Potência Feminista, Ou O Desejo de Transformar Tudo

Verónica Gago

2020EPUB854 KB

Journals & papers

ICASSP 2021 - 2021 IEEE International Conference on Acoustics, Speech and Signal Processing

Pahar, Madhurananda & 6 more

2021PDF2.6 MB

First-line Cemiplimab Monotherapy and Continued Cemiplimab Beyond Progression Plus Chemotherapy for Advanced Non-small-cell Lung Cancer with PD-L1 50% or More (EMPOWER-Lung 1): 35-month Follow-up from a Mutlicentre, Open-label, Randomised, Phase 3 Trial

Özgüroğlu, Mustafa & 46 more

2023PDF1.0 MB

Renal Infarction Secondary to Aspergillus Spp. Embolism Following COVID-19

de Menezes Neves, Precil Diego Miranda & 20 more

2024PDF1.1 MB

Urban Policy in the Framework of the 2030 Agenda

María Ángeles Huete García, Adrián Rodríguez Miranda & 2 more

2023PDF6.2 MB

Cemiplimab Monotherapy for First-line Treatment of Advanced Non-small-cell Lung Cancer with PD-L1 of at Least 50%

Sezer, Ahmet & 52 more

2021PDF5.2 MB

Genres

Books

Full Elucidation of the Transmembrane Anion Transport Mechanism of Squaramides Using in Silico Investigations

A Potência Feminista, Ou O Desejo de Transformar Tudo

Journals & papers

ICASSP 2021 - 2021 IEEE International Conference on Acoustics, Speech and Signal Processing

First-line Cemiplimab Monotherapy and Continued Cemiplimab Beyond Progression Plus Chemotherapy for Advanced Non-small-cell Lung Cancer with PD-L1 50% or More (EMPOWER-Lung 1): 35-month Follow-up from a Mutlicentre, Open-label, Randomised, Phase 3 Trial

Renal Infarction Secondary to Aspergillus Spp. Embolism Following COVID-19

Urban Policy in the Framework of the 2030 Agenda

Cemiplimab Monotherapy for First-line Treatment of Advanced Non-small-cell Lung Cancer with PD-L1 of at Least 50%

Genres

Genres

Books

Full Elucidation of the Transmembrane Anion Transport Mechanism of Squaramides Using in Silico Investigations

A Potência Feminista, Ou O Desejo de Transformar Tudo

Journals & papers

ICASSP 2021 - 2021 IEEE International Conference on Acoustics, Speech and Signal Processing

First-line Cemiplimab Monotherapy and Continued Cemiplimab Beyond Progression Plus Chemotherapy for Advanced Non-small-cell Lung Cancer with PD-L1 50% or More (EMPOWER-Lung 1): 35-month Follow-up from a Mutlicentre, Open-label, Randomised, Phase 3 Trial

Renal Infarction Secondary to Aspergillus Spp. Embolism Following COVID-19

Urban Policy in the Framework of the 2030 Agenda

Cemiplimab Monotherapy for First-line Treatment of Advanced Non-small-cell Lung Cancer with PD-L1 of at Least 50%